Point of Care sells drugs-of-abuse test to Dade
This article was originally published in Clinica
Executive Summary
Point of Care Technologies has sold its Genie Cup urine-based drugs-of-abuse testing technology to Dade Behring for a sum of between $15 million and $24 million, depending on due diligence and definitive identification of assets.